Who owns Inotek Pharmaceuticals?

Top Holders and Investors of Inotek Pharmaceuticals Stock

Find out what company owns Inotek Pharmaceuticals, who bought Inotek Pharmaceuticals this quarter, and who sold shares of Inotek Pharmaceuticals stock?

Fund or Company Name Number of Shares Valued At As Of
Opaleye Management 1.80M $3.21M Sep 2017
Jennison Associates 1.56M $2.77M Sep 2017
Adage Capital Partners GP 1.50M $2.67M Sep 2017
Pura Vida Investments 1.15M $2.04M Sep 2017
Senzar Asset Management 781922 $1.39M Sep 2017
Point72 Asset Management 635465 $1.13M Sep 2017
Vanguard 618552 $1.06M Sep 2017
BlackRock Fund Advisors 552073 $3.37M Dec 2016
BlackRock Institutional Trust Company, N.A. 412323 $2.52M Dec 2016
Sphera Funds Management 401764 $715139 Sep 2017
GSA Capital Partners 367300 $653794 Sep 2017
BlackRock 334445 $565212 Sep 2017
BlackRock Advisors 285706 $1.74M Dec 2016
EverPoint Asset Management 235726 $1.44M Dec 2016
Millennium Management 201509 $358686 Sep 2017
BlackRock 146607 $894302 Dec 2016
D. E. Shaw & Co 140122 $249417 Sep 2017
Boothbay Fund Management 139731 $248721 Sep 2017
Squarepoint Ops 126963 $225994 Sep 2017
Geode Capital Management 102964 $183275 Sep 2017
BlackRock Investment Management 80392 $490391 Dec 2016
Morgan Stanley 67432 $134864 Mar 2017
LMR Partners 66533 $126412 Jun 2017
R&F Capital Advisors 39110 $77828 Mar 2017
FT Options 34900 $62820 Sep 2017
Northern Trust 26388 $46970 Sep 2017
Bank of New York Mellon 25033 $48313 Jun 2017
KCG Holdings 18392 $34944 Jun 2017
Citadel Advisors 16190 $28980 Sep 2017
Group One Trading 15922 $28022 Sep 2017
A.R.T. Advisors 15478 $26931 Sep 2017
Columbus Circle Investors 15000 $27000 Sep 2017
Guggenheim Capital, LLC Managers 10441 $19002 Sep 2017
Meridian Investment Counsel 10000 $19000 Sep 2017
Rathbones Brothers 10000 $18000 Sep 2017
Jpmorgan Chase & Co 8807 $16997 Jun 2017
Deutsche Bank Aktiengesellschaft 8144 $14007 Sep 2017
Simplex Trading 5440 $8976 Sep 2017
Cutler 3300 $5511 Sep 2017
Meeder Asset Management 3064 $4994 Sep 2017
FNY Partners Fund 2000 $4000 Mar 2017
Manchester Capital Management 400 $1000 Jun 2017
Bnp Paribas Arbitrage, Snc 4 $7 Sep 2017
Barclays 3 $0 Sep 2017

Who sold Inotek Pharmaceuticals?

Fund Name Date Sold Shares Held Valued At
Rho Capital Partners June 30, 2017 2.63M $4.99M
DLD Asset Management June 30, 2017 496700 $933796
DAFNA Capital Management June 30, 2017 237135 $450556
Sabby Management June 30, 2017 212651 $404
Goldman Sachs June 30, 2017 173690 $330011
PanAgora Asset Management June 30, 2017 154213 $293004
Susquehanna International June 30, 2017 149775 $284572
Element Capital Management June 30, 2017 91975 $174752
Minerva Advisors June 30, 2017 64759 $119804
Worth Venture Partners June 30, 2017 62700 $11913
Sunrise Partners Limited Partnership June 30, 2017 62700 $119130
Dimensional Fund Advisors June 30, 2017 35881 $68173
Rhumbline Advisers March 31, 2017 29825 $59948
Parametric Portfolio Associates June 30, 2017 28243 $53944
GRT Capital Partners June 30, 2017 20500 $38950
New York State Common Retirement Fund March 31, 2017 17901 $35981
Wells Fargo & Company March 31, 2017 16526 $33052
Bank of America Corporation March 31, 2017 16343 $32522
Graticule Asia Macro Advisors June 30, 2017 16217 $30974
Virtu Financial June 30, 2017 16173 $31052
State Street Corporation June 30, 2017 14700 $27048
Nationwide Fund Advisors March 31, 2017 10987 $21974
American International March 31, 2017 10745 $20952
Tower Research Capital June 30, 2017 5998 $10976
Royal Bank of Canada Dec. 31, 2016 2546 $14614
Legal & General March 31, 2017 1975 $4009
Manufacturers Life Insurance Company June 30, 2017 800 $2000
UBS Group AG June 30, 2017 189 $0
Citi June 30, 2017 1 $0